Global Oligonucleotide Synthesis Linkers Market Research Report 2025(Status and Outlook)

Report Overview

The chemical synthesis of relatively short segments of nucleic acids with defined chemical structure is known as oligonucleotide synthesis. The method is particularly valuable in recent laboratory practice since it allows for quick and low-cost access to custom-made oligonucleotides of the appropriate sequence. The future use of customized therapy to cure chronic illnesses is ideal because to oligonucleotide synthesis.

This report provides a deep insight into the global Oligonucleotide Synthesis Linkers market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oligonucleotide Synthesis Linkers Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oligonucleotide Synthesis Linkers market in any manner.

Global Oligonucleotide Synthesis Linkers Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Agilent Technologies

Inc

ATDBio Ltd

Bio-Synthesis Inc

BioAutomation

LGC Biosearch Technologies

Sarepta Therapeutics

Kaneka Corporation

GeneDesign

Inc

General Electric

GenScript

Integrated DNA Technologies

Inc

NITTO DENKO CORPORATION

Thermo Fisher Scientific

Inc

TriLink BioTechnologies

Danaher

Maravai LifeSciences

Biogen

Eurofins Scientific

Merck KGaA

Huzhou Hippo Biotechnology Co.

Ltd.

Market Segmentation (by Type)

Single-Ended Index Connector

Double-Ended Index Connector

Market Segmentation (by Application)

Molecular Detection

Genetic Diagnosis

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Oligonucleotide Synthesis Linkers Market

Overview of the regional outlook of the Oligonucleotide Synthesis Linkers Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oligonucleotide Synthesis Linkers Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oligonucleotide Synthesis Linkers
1.2 Key Market Segments
1.2.1 Oligonucleotide Synthesis Linkers Segment by Type
1.2.2 Oligonucleotide Synthesis Linkers Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oligonucleotide Synthesis Linkers Market Overview
2.1 Global Market Overview
2.1.1 Global Oligonucleotide Synthesis Linkers Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Oligonucleotide Synthesis Linkers Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oligonucleotide Synthesis Linkers Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Oligonucleotide Synthesis Linkers Product Life Cycle
3.3 Global Oligonucleotide Synthesis Linkers Sales by Manufacturers (2020-2025)
3.4 Global Oligonucleotide Synthesis Linkers Revenue Market Share by Manufacturers (2020-2025)
3.5 Oligonucleotide Synthesis Linkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oligonucleotide Synthesis Linkers Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Oligonucleotide Synthesis Linkers Manufacturing Sites, Area Served, Product Type
3.8 Oligonucleotide Synthesis Linkers Market Competitive Situation and Trends
3.8.1 Oligonucleotide Synthesis Linkers Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oligonucleotide Synthesis Linkers Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Oligonucleotide Synthesis Linkers Industry Chain Analysis
4.1 Oligonucleotide Synthesis Linkers Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oligonucleotide Synthesis Linkers Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oligonucleotide Synthesis Linkers Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Oligonucleotide Synthesis Linkers Market
5.7 ESG Ratings of Leading Companies
6 Oligonucleotide Synthesis Linkers Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oligonucleotide Synthesis Linkers Sales Market Share by Type (2020-2025)
6.3 Global Oligonucleotide Synthesis Linkers Market Size Market Share by Type (2020-2025)
6.4 Global Oligonucleotide Synthesis Linkers Price by Type (2020-2025)
7 Oligonucleotide Synthesis Linkers Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oligonucleotide Synthesis Linkers Market Sales by Application (2020-2025)
7.3 Global Oligonucleotide Synthesis Linkers Market Size (M USD) by Application (2020-2025)
7.4 Global Oligonucleotide Synthesis Linkers Sales Growth Rate by Application (2020-2025)
8 Oligonucleotide Synthesis Linkers Market Sales by Region
8.1 Global Oligonucleotide Synthesis Linkers Sales by Region
8.1.1 Global Oligonucleotide Synthesis Linkers Sales by Region
8.1.2 Global Oligonucleotide Synthesis Linkers Sales Market Share by Region
8.2 Global Oligonucleotide Synthesis Linkers Market Size by Region
8.2.1 Global Oligonucleotide Synthesis Linkers Market Size by Region
8.2.2 Global Oligonucleotide Synthesis Linkers Market Size Market Share by Region
8.3 North America
8.3.1 North America Oligonucleotide Synthesis Linkers Sales by Country
8.3.2 North America Oligonucleotide Synthesis Linkers Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oligonucleotide Synthesis Linkers Sales by Country
8.4.2 Europe Oligonucleotide Synthesis Linkers Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oligonucleotide Synthesis Linkers Sales by Region
8.5.2 Asia Pacific Oligonucleotide Synthesis Linkers Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oligonucleotide Synthesis Linkers Sales by Country
8.6.2 South America Oligonucleotide Synthesis Linkers Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oligonucleotide Synthesis Linkers Sales by Region
8.7.2 Middle East and Africa Oligonucleotide Synthesis Linkers Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Oligonucleotide Synthesis Linkers Market Production by Region
9.1 Global Production of Oligonucleotide Synthesis Linkers by Region(2020-2025)
9.2 Global Oligonucleotide Synthesis Linkers Revenue Market Share by Region (2020-2025)
9.3 Global Oligonucleotide Synthesis Linkers Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oligonucleotide Synthesis Linkers Production
9.4.1 North America Oligonucleotide Synthesis Linkers Production Growth Rate (2020-2025)
9.4.2 North America Oligonucleotide Synthesis Linkers Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oligonucleotide Synthesis Linkers Production
9.5.1 Europe Oligonucleotide Synthesis Linkers Production Growth Rate (2020-2025)
9.5.2 Europe Oligonucleotide Synthesis Linkers Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oligonucleotide Synthesis Linkers Production (2020-2025)
9.6.1 Japan Oligonucleotide Synthesis Linkers Production Growth Rate (2020-2025)
9.6.2 Japan Oligonucleotide Synthesis Linkers Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oligonucleotide Synthesis Linkers Production (2020-2025)
9.7.1 China Oligonucleotide Synthesis Linkers Production Growth Rate (2020-2025)
9.7.2 China Oligonucleotide Synthesis Linkers Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Agilent Technologies
10.1.1 Agilent Technologies Basic Information
10.1.2 Agilent Technologies Oligonucleotide Synthesis Linkers Product Overview
10.1.3 Agilent Technologies Oligonucleotide Synthesis Linkers Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Inc
10.2.1 Inc Basic Information
10.2.2 Inc Oligonucleotide Synthesis Linkers Product Overview
10.2.3 Inc Oligonucleotide Synthesis Linkers Product Market Performance
10.2.4 Inc Business Overview
10.2.5 Inc SWOT Analysis
10.2.6 Inc Recent Developments
10.3 ATDBio Ltd
10.3.1 ATDBio Ltd Basic Information
10.3.2 ATDBio Ltd Oligonucleotide Synthesis Linkers Product Overview
10.3.3 ATDBio Ltd Oligonucleotide Synthesis Linkers Product Market Performance
10.3.4 ATDBio Ltd Business Overview
10.3.5 ATDBio Ltd SWOT Analysis
10.3.6 ATDBio Ltd Recent Developments
10.4 Bio-Synthesis Inc
10.4.1 Bio-Synthesis Inc Basic Information
10.4.2 Bio-Synthesis Inc Oligonucleotide Synthesis Linkers Product Overview
10.4.3 Bio-Synthesis Inc Oligonucleotide Synthesis Linkers Product Market Performance
10.4.4 Bio-Synthesis Inc Business Overview
10.4.5 Bio-Synthesis Inc Recent Developments
10.5 BioAutomation
10.5.1 BioAutomation Basic Information
10.5.2 BioAutomation Oligonucleotide Synthesis Linkers Product Overview
10.5.3 BioAutomation Oligonucleotide Synthesis Linkers Product Market Performance
10.5.4 BioAutomation Business Overview
10.5.5 BioAutomation Recent Developments
10.6 LGC Biosearch Technologies
10.6.1 LGC Biosearch Technologies Basic Information
10.6.2 LGC Biosearch Technologies Oligonucleotide Synthesis Linkers Product Overview
10.6.3 LGC Biosearch Technologies Oligonucleotide Synthesis Linkers Product Market Performance
10.6.4 LGC Biosearch Technologies Business Overview
10.6.5 LGC Biosearch Technologies Recent Developments
10.7 Sarepta Therapeutics
10.7.1 Sarepta Therapeutics Basic Information
10.7.2 Sarepta Therapeutics Oligonucleotide Synthesis Linkers Product Overview
10.7.3 Sarepta Therapeutics Oligonucleotide Synthesis Linkers Product Market Performance
10.7.4 Sarepta Therapeutics Business Overview
10.7.5 Sarepta Therapeutics Recent Developments
10.8 Kaneka Corporation
10.8.1 Kaneka Corporation Basic Information
10.8.2 Kaneka Corporation Oligonucleotide Synthesis Linkers Product Overview
10.8.3 Kaneka Corporation Oligonucleotide Synthesis Linkers Product Market Performance
10.8.4 Kaneka Corporation Business Overview
10.8.5 Kaneka Corporation Recent Developments
10.9 GeneDesign
10.9.1 GeneDesign Basic Information
10.9.2 GeneDesign Oligonucleotide Synthesis Linkers Product Overview
10.9.3 GeneDesign Oligonucleotide Synthesis Linkers Product Market Performance
10.9.4 GeneDesign Business Overview
10.9.5 GeneDesign Recent Developments
10.10 Inc
10.10.1 Inc Basic Information
10.10.2 Inc Oligonucleotide Synthesis Linkers Product Overview
10.10.3 Inc Oligonucleotide Synthesis Linkers Product Market Performance
10.10.4 Inc Business Overview
10.10.5 Inc Recent Developments
10.11 General Electric
10.11.1 General Electric Basic Information
10.11.2 General Electric Oligonucleotide Synthesis Linkers Product Overview
10.11.3 General Electric Oligonucleotide Synthesis Linkers Product Market Performance
10.11.4 General Electric Business Overview
10.11.5 General Electric Recent Developments
10.12 GenScript
10.12.1 GenScript Basic Information
10.12.2 GenScript Oligonucleotide Synthesis Linkers Product Overview
10.12.3 GenScript Oligonucleotide Synthesis Linkers Product Market Performance
10.12.4 GenScript Business Overview
10.12.5 GenScript Recent Developments
10.13 Integrated DNA Technologies
10.13.1 Integrated DNA Technologies Basic Information
10.13.2 Integrated DNA Technologies Oligonucleotide Synthesis Linkers Product Overview
10.13.3 Integrated DNA Technologies Oligonucleotide Synthesis Linkers Product Market Performance
10.13.4 Integrated DNA Technologies Business Overview
10.13.5 Integrated DNA Technologies Recent Developments
10.14 Inc
10.14.1 Inc Basic Information
10.14.2 Inc Oligonucleotide Synthesis Linkers Product Overview
10.14.3 Inc Oligonucleotide Synthesis Linkers Product Market Performance
10.14.4 Inc Business Overview
10.14.5 Inc Recent Developments
10.15 NITTO DENKO CORPORATION
10.15.1 NITTO DENKO CORPORATION Basic Information
10.15.2 NITTO DENKO CORPORATION Oligonucleotide Synthesis Linkers Product Overview
10.15.3 NITTO DENKO CORPORATION Oligonucleotide Synthesis Linkers Product Market Performance
10.15.4 NITTO DENKO CORPORATION Business Overview
10.15.5 NITTO DENKO CORPORATION Recent Developments
10.16 Thermo Fisher Scientific
10.16.1 Thermo Fisher Scientific Basic Information
10.16.2 Thermo Fisher Scientific Oligonucleotide Synthesis Linkers Product Overview
10.16.3 Thermo Fisher Scientific Oligonucleotide Synthesis Linkers Product Market Performance
10.16.4 Thermo Fisher Scientific Business Overview
10.16.5 Thermo Fisher Scientific Recent Developments
10.17 Inc
10.17.1 Inc Basic Information
10.17.2 Inc Oligonucleotide Synthesis Linkers Product Overview
10.17.3 Inc Oligonucleotide Synthesis Linkers Product Market Performance
10.17.4 Inc Business Overview
10.17.5 Inc Recent Developments
10.18 TriLink BioTechnologies
10.18.1 TriLink BioTechnologies Basic Information
10.18.2 TriLink BioTechnologies Oligonucleotide Synthesis Linkers Product Overview
10.18.3 TriLink BioTechnologies Oligonucleotide Synthesis Linkers Product Market Performance
10.18.4 TriLink BioTechnologies Business Overview
10.18.5 TriLink BioTechnologies Recent Developments
10.19 Danaher
10.19.1 Danaher Basic Information
10.19.2 Danaher Oligonucleotide Synthesis Linkers Product Overview
10.19.3 Danaher Oligonucleotide Synthesis Linkers Product Market Performance
10.19.4 Danaher Business Overview
10.19.5 Danaher Recent Developments
10.20 Maravai LifeSciences
10.20.1 Maravai LifeSciences Basic Information
10.20.2 Maravai LifeSciences Oligonucleotide Synthesis Linkers Product Overview
10.20.3 Maravai LifeSciences Oligonucleotide Synthesis Linkers Product Market Performance
10.20.4 Maravai LifeSciences Business Overview
10.20.5 Maravai LifeSciences Recent Developments
10.21 Biogen
10.21.1 Biogen Basic Information
10.21.2 Biogen Oligonucleotide Synthesis Linkers Product Overview
10.21.3 Biogen Oligonucleotide Synthesis Linkers Product Market Performance
10.21.4 Biogen Business Overview
10.21.5 Biogen Recent Developments
10.22 Eurofins Scientific
10.22.1 Eurofins Scientific Basic Information
10.22.2 Eurofins Scientific Oligonucleotide Synthesis Linkers Product Overview
10.22.3 Eurofins Scientific Oligonucleotide Synthesis Linkers Product Market Performance
10.22.4 Eurofins Scientific Business Overview
10.22.5 Eurofins Scientific Recent Developments
10.23 Merck KGaA
10.23.1 Merck KGaA Basic Information
10.23.2 Merck KGaA Oligonucleotide Synthesis Linkers Product Overview
10.23.3 Merck KGaA Oligonucleotide Synthesis Linkers Product Market Performance
10.23.4 Merck KGaA Business Overview
10.23.5 Merck KGaA Recent Developments
10.24 Huzhou Hippo Biotechnology Co.
10.24.1 Huzhou Hippo Biotechnology Co. Basic Information
10.24.2 Huzhou Hippo Biotechnology Co. Oligonucleotide Synthesis Linkers Product Overview
10.24.3 Huzhou Hippo Biotechnology Co. Oligonucleotide Synthesis Linkers Product Market Performance
10.24.4 Huzhou Hippo Biotechnology Co. Business Overview
10.24.5 Huzhou Hippo Biotechnology Co. Recent Developments
10.25 Ltd.
10.25.1 Ltd. Basic Information
10.25.2 Ltd. Oligonucleotide Synthesis Linkers Product Overview
10.25.3 Ltd. Oligonucleotide Synthesis Linkers Product Market Performance
10.25.4 Ltd. Business Overview
10.25.5 Ltd. Recent Developments
11 Oligonucleotide Synthesis Linkers Market Forecast by Region
11.1 Global Oligonucleotide Synthesis Linkers Market Size Forecast
11.2 Global Oligonucleotide Synthesis Linkers Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oligonucleotide Synthesis Linkers Market Size Forecast by Country
11.2.3 Asia Pacific Oligonucleotide Synthesis Linkers Market Size Forecast by Region
11.2.4 South America Oligonucleotide Synthesis Linkers Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oligonucleotide Synthesis Linkers by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Oligonucleotide Synthesis Linkers Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Oligonucleotide Synthesis Linkers by Type (2026-2033)
12.1.2 Global Oligonucleotide Synthesis Linkers Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Oligonucleotide Synthesis Linkers by Type (2026-2033)
12.2 Global Oligonucleotide Synthesis Linkers Market Forecast by Application (2026-2033)
12.2.1 Global Oligonucleotide Synthesis Linkers Sales (K MT) Forecast by Application
12.2.2 Global Oligonucleotide Synthesis Linkers Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings